Home QTc interval predicts disturbed circadian blood pressure variation
Article Open Access

QTc interval predicts disturbed circadian blood pressure variation

  • Liyuan Yan , Jianling Jin , Shili Jiang , Wei Zhu , Meiwen Gao , Xin Zhao and Jiamin Yuan EMAIL logo
Published/Copyright: March 6, 2020

Abstract

Background

The relationship between electrocardiographic evaluation and circadian blood pressure (BP) variation in young and middle-aged hypertensive patients remains unknown.

Methods

A total of 171 hypertensive patients were included in the study. First, patients were divided into a young and middle-aged group and an elderly group. The two groups were then separately classified into three subgroups on the basis of circadian variation of BP as dippers, non-dippers and reverse-dippers. The electrocardiographic evaluation was calculated from 12-lead electrocardiography (ECG).

Results

QTc intervals were shortest in the dippers and longest in the reverse-dippers in the young and middle-aged group (QTc dipper: 416.53±18.37ms; non-dipper: 438.30±29.71ms; reverse-dipper: 444.93±25.47ms; for dipper vs non-dipper, and dipper vs reverse-dipper P<0.05). QTc interval was found to be an independent risk factor for the non-dipper BP pattern (Odds ratio 1.049; 95% CI 1.01-1.089; P=0.012) and reverse-dipper BP pattern (Odds ratio 1.051; 95% CI 1.007-1.098; P=0.023) in young and middle-aged hypertensive patients. No significant differences in other ECG parameters were found among the three subgroups in the young and middle-aged group.

Conclusion

Our study suggested that QTc interval might serve as a risk factor for non-dipper BP pattern and reverse-dipper BP pattern in young and middle-aged hypertensive patients.

1 Introduction

Hypertension, ranking among the most prevalent chronic diseases, not only causes health loss by itself, but also acts as an independent risk factor for many other diseases, such as stroke, heart failure, renal failure and coronary artery disease [1]. To prevent target organ damage and cardiovascular events, the latest hypertension guidelines recommend early, strict and all-day blood pressure control [2, 3]. Therefore, ambulatory blood pressure monitoring (ABPM) is increasingly used in clinical practice to analyze circadian BP variation, to detect nocturnal hypertension and to evaluate the efficacy of antihypertensive drugs [4]. Circadian BP variation is quantified through the diurnal/nocturnal BP ratio. Based on it, BP rhythms can be divided into four categories, which are known as extreme-dipper, dipper, non-dipper and reverse-dipper [5]. Studies have shown that blunted nocturnal blood pressure dipping is related to damage of end organs and to cardiovascular mortality [6, 7].

There have been several studies investigating the association between electrocardiographic evaluation [eg: heart rate , frontal QRS-T angle, QTc interval, Tpeak to Tend interval and left ventricular hypertrophy (LVH)] and the circadian variation of BP [8, 9, 10]. However, the effect of circadian variation of BP on electrocardiographic evaluation remains controversial. What’s more, to the best of our knowledge, there is no study investigating the relationship between electrocardiographic evaluation and BP reverse dipping status in young and middle-aged patients with essential hypertension. Therefore, this study is designed to further investigate the relationship between electrocardiographic evaluation and circadian BP variation in young and middle-aged hypertensive patients.

2 Methods

2.1 Study population

This single-center study retrospectively included hypertensive patients admitted to the Cardiology department at the first Affiliated Hospital of Soochow University who simultaneously underwent ECG and ABPM from January 2017 to January 2019. Hypertension was defined as previously diagnosed hypertension, currently using antihypertensive drugs, office-measured systolic BP (SBP)/diastolic BP (DBP)≥140/90 mmHg, 24h ABPM SBP/DBP≥130/80 mmHg, daytime (or awake) ABPM SBP/DBP≥135/85 mmHg or nighttime (or sleep) ABPM SBP/DBP≥120/70 mmHg[3]. Patients with age < 60 years old were considered as young and middle-aged patients, while those with age ≥ 60 years old were defined as elderly patients [11, 12]. Body mass index was calculated as weight in kilograms divided by the square of the height in meters. The patients were excluded if they 1) had incomplete medical records; 2) were <18 or >90 years old; 3) were taking drugs that may affect QTc interval duration in addition to antihypertensive drugs; 4) also had secondary hypertension, atrial fibrillation, atrial flutter, bundle branch block, II/III-degree atrioventricular block, pre-excitation, paced rhythm, diabetes mellitus, chronic liver disease, chronic renal disease, acute coronary syndrome, moderate or severe valvular disease, chronic obstructive pulmonary disease, thyroid function disorders, electrolyte imbalance, heart failure, obstructive sleep apnea syndrome or malignant tumor.

There were only two extreme-dippers meeting the above inclusion and exclusion criteria. Due to the limited numbers, the two extreme-dippers were not included in our study. In the end, a total of 171 patients were included in the study. They were first divided into two groups, the young and middle-aged group and the elderly group. Then, the above two groups were separately classified into three subgroups on the basis of circadian variation of BP, as dipper, non-dipper and reverse-dipper.

2.2 ABPM recordings

ABPM was performed to record the circadian variation of blood pressure in all included patients by an ABPM 6100 device (Welch Allyn Corp., NY, USA). The cuff was placed on the right arm of patients. Patients were asked to keep their daily routine and stay calm when feeling the inflation of cuff. During the daytime (8:00AM to 11:00PM), BP was measured every 15 minutes. During the nighttime (11:00PM to 8:00AM), BP was measured every 30 minutes. Only recordings with more than 70% of valid BP measurements were included in the final analysis. The means of SBP and DBP were calculated at 24 h, awake and sleep. The nocturnal dip rate was calculated as follows: (%) 100× [1− (average night SBP/average awake SBP)]. Then, the circadian variation of blood pressure status was defined as: extreme-dipper (nocturnal dip rate ≥20%), dipper (10%≤ nocturnal dip rate <20%), non-dipper (0≤nocturnal dip rate<10%) and reverse-dipper (nocturnal dip rate <0) [5].

2.3 Electrocardiographic evaluation

All patients included in the study underwent a resting 12-lead ECG (Nalong Corp., Xiamen, China) with a 25mm/s paper speed and 10 mm/mV height. Heart rate and frontal QRS-T angle were obtained directly from ECG reports. The QT intervals were measured using a software program (Nalong Corp., Xiamen, China). Then we recorded the longest QT interval from all limb and precordial leads and QTc interval was calculated using Bazett’s formula[13]. QTc interval >450ms for men and >460ms for women was considered prolonged. Tpeak to Tend (TpTe) interval was measured manually from the peak to the end of the T-wave at the lead V5 when possible [14]. Left ventricular hypertrophy was defined according to Cornell criteria (RaVL+SV3 >28mm for men and >20mm for women) or Sokolow-Lyon (SV1+RV5,6 ≥35mm) [15, 16].

2.4 Laboratory tests

Baseline demographic, clinical and laboratory data were collected from the hospital medical records and case collection and scientific research system for clinical cardiology (CCSSSCC). Peripheral blood samples were drawn from patients when they were in a fasting state. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and other biochemical parameters were determined at the Biochemistry Department in the first Affiliated Hospital of Soochow University.

2.5 Statistical analysis

Statistical analysis was performed using IBM SPSS for Windows version 25.0 (IBM Corp., Armonk, NY, USA). Continuous variables were tested for a normal distribution using the Shapiro-Wilk test. Continuous variables with a normal distribution were defined as mean±standard deviation (SD), while continuous variables without a normal distribution were defined as median (interquartile range, IQR). Continuous variables were compared using the one way analysis of variance (ANOVA) or the Kruskal-Wallis test, if appropriate. If the results of ANOVA were statistically significant, post-hoc Bonferroni test was performed. If the results of Kruskal-Wallis test were statistically significant, the results of pairwise comparison were corrected by Bonferroni correction. Categorical variables, defined as percentages, were compared using the χ2-test or the Fisher’s exact test, if appropriate. To assess the correlation between continuous variables, Pearson’s correlation coefficients were calculated. To explore the relationship between relevant variables and circadian blood pressure rhythm, multivariate logistic regression analyses were applied. For all analyses, values of P less than 0.05 were regarded to be statistically significant.

Ethical issues: Our study was in accordance with the principles outlined in the Declaration of Helsinki and approved by the ethics committee of Soochow University.

Informed consent: Informed consent has been obtained from all individuals included in this study.

3 Results

In the end, a total of 171 patients were included in our study. The baseline demographic and clinical characteristics are shown in Table 1. In the young and middle-aged group, there were significant differences with respect to age, use of diuretics, sleep SBP and sleep DBP among dippers, non-dippers and reverse-dippers [age: 36 (29~48) vs 49 (39~53) vs 47 (51~54) years old in dippers, non-dippers and reverse-dippers, respectively, P=0.048; use of diuretics: 0 (0%) vs 12 (30.0%) vs 5 (35.7%) in dippers, non-dippers and reverse-dippers, respectively, P=0.026; sleep SBP:118 (108~124) vs 118 (108~138) vs 141 (122~167) mmHg in dippers, non-dippers and reverse-dippers, respectively, P=0.006; sleep DBP: 68 (60~81) vs 72 (64~83) vs 86 (70~93) mmHg in dippers, non-dippers and reverse-dippers, respectively, P=0.044]. Other characteristics were similar among the three subgroups in young and middle-aged patients. In the elderly group, there were only sleep SBP and sleep DBP showing significant differences among the three subgroups [sleep SBP: 118 (104~124) vs 123 (112~131) vs 128 (118~142) mmHg in dippers, non-dippers and reverse-dippers, respectively, P=0.015; sleep DBP: 59 (56~64) vs 66 (60~71) vs 69 (63~76) mmHg in dippers, non-dippers and reverse-dippers, respectively, P=0.016].

Table 1

Demographic and clinical characteristics of included patients.

Young and middle-aged patients (n=69)Elderly patients (n=102)
Dipper (n=15)Non-dipper (n=40)Reverse-dipper (n=14)PDipper (n=10)Non-dipper (n=48)Reverse-dipper (n=44)P
Age, years36 (29~48)49 (39~53)47 (51~54)0.04868 (63~70)68 (62~71)66 (64~71)0.960
Sex, male, n (%)10 (66.7)21 (52.5)7 (50)0.5862 (20.0)17 (35.4)17 (38.6)0.628
BMI, kg/m224.53±3.3624.40±3.7226.15±3.220.27823.62±2.8224.47±3.3425.05±3.050.392
Smoking, n (%)4 (26.7)9 (22.5)2 (14.3)0.7291 (10.0)1 (2.1)5 (11.4)0.126
Drinking, n (%)4 (26.7)4 (10.0)2 (14.3)0.3201 (10.0)1 (2.1)2 (4.5)0.303
Medications, n (%)
    ACEI/ARBs7 (46.7)22 (55.0)10 (71.4)0.3877 (70.0)33 (68.8)31 (70.5)1.000
    β-Blockers4 (26.7)23 (57.5)7 (50.0)0.1255 (50.0)20 (41.7)22 (50.0)0.737
    CCBs9 (60.0)26 (65.0)11 (78.6)0.5678 (80.0)31 (64.6)23 (52.3)0.219
    Diuretics0 (0)12 (30.0)5 (35.7)0.026[a][b]3 (30.0)16 (33.3)9 (20.5)0.375
24h SBP, mmHg132 (122~136)123 (116~143)138 (120~154)0.227129 (116~138)128 (115~134)123 (113~136)0.783
24h DBP, mmHg79 (72~92)77 (69~85)80 (68~93)0.77969 (62~74)68 (62~75)68 (61~75)0.938
Awake SBP, mmHg135 (128~140)126 (119~144)135 (119~152)0.178132 (120~143)130 (117~136)122 (112~135)0.216
Awake DBP, mmHg85 (76~95)79 (70~88)77 (68~91)0.43572 (65~78)68 (62~76)68 (60~75)0.360
Sleep SBP, mmHg118 (108~124)118 (108~138)141 (122~167)0.006[b][c]118 (104~124)123 (112~131)128 (118~142)0.015
Sleep DBP, mmHg68 (60~81)72 (64~83)86 (70~93)0.044[b]59 (56~64)66 (60~71)69 (63~76)0.016[b]
  1. Normally distributed data are presented as means ± standard deviation (SD), skewed data are presented as the median (interquartile range), and categorical data are presented as a number (percentage). Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; CCB, calcium channel blocker; DBP, diastolic blood pressure; SBP, systolic blood pressure. Values in bold indicate statistical significance (p < 0.05).

The laboratory and electrocardiographic variables of the study population are shown in the Table 2. There were no significant differences in serum levels of creatinine, ALT, AST, potassium (K) and sodium (Na) among the three subgroups in the young and middle-aged group or the elderly group. Heart rate, TpTe, frontal QRS-T angle and the number of patients with electrocardiographic LVH were similar among the dippers, non-dippers and reverse-dippers in the young and middle-aged group. QTc interval and the number of patients with prolonged QTc interval were significantly different among the three subgroups in young and middle-aged hypertensive patients [QTc interval: 416.53±18.37 vs 438.30±29.71 vs 444.93±25.47ms in dippers, non-dippers and reverse-dippers, respectively, P=0.011 (Figure 1); the number of patients with prolonged QTc interval was: 0(0%) vs 12(30.0%) vs 4(28.6%) in dippers, non-dippers and reverse-dippers, respectively, P=0.035]. However, in the elderly group, both QTc interval and the number of patients with prolonged QTc interval were similar among the three subgroups, as were TpTe, frontal QRS-T angle and the number of patients with electrocardiographic LVH. Only heart rate was significantly different among dippers, non-dippers and reverse-dippers in elderly patients with essential hypertension (heart rate:69.90±8.81 vs 71.88±11.16 vs 66.07±9.32 beats per minute in dippers, non-dippers and reverse-dippers, respectively, P=0.027).

Figure 1 QTc interval given separately for dippers, non-dippers and reverse-dippers in young and middle-aged patients.
Figure 1

QTc interval given separately for dippers, non-dippers and reverse-dippers in young and middle-aged patients.

Table 2

Laboratory and electrocardiographic variables of the young and middle-aged and elderly patients given separately for dippers, non-dippers and reverse-dippers.

Young and middle-aged patients (n=69)Elderly patients (n=102)
Dipper (n=15)Non dipper (n=40)Reverse dipper (n=14)PDipper (n=10)Non dipper (n=48)Reverse dipper (n=44)P
Laboratory variables
    Creatinine, umol/L70 (55~76)66 (53~77)66 (52~85)0.83062 (57~68)60 (53~72)64 (54~80)0.803
    ALT, U/L20 (17~43)21 (13~30)24 (16~41)0.46522 (10~27)18 (14~24)19 (14~28)0.790
    AST, U/L17 (13~26)19 (17~23)18 (15~21)0.73422 (16~24)20 (17~25)21 (17~26)0.759
    K, mmol/L4.02±0.413.87±0.353.73±0.480.1593.73(3.53~4.01)3.90(3.68~4.10)3.86(3.61~4.11)0.452
    Na, mmol/L141 (139~143)140.7 (140~143)140 (140~142)0.735141 (140~143)142 (140~143)142 (140~143)0.652
ECG variables
        Heart rate, beats /min76.07±17.8076.30±12.7476.50±11.660.99669.90±8.8171.88±11.1666.07±9.320.027[c]
        QTc, ms416.53±18.37438.30±29.71444.93±25.470.011[a][b]438.80±19.46443.29±25.37434.82±25.790.274
        Prolonged QTc, n (%)0 (0.0)12 (30.0)4 (28.6)0.035[a][b]2 (20.0)14 (29.2)10 (22.7)0.754
        TpTe, ms89.40±13.9092.33±15.9193.86±21.800.76486.30±26.1087.40±22.5495.82±22.390.172
        Frontal QRS-T angle,°10 (4~21)9 (4~17)11 (4~45)0.58918 (2~76)18 (10~35)17 (8~28)0.869
        ECG LVH, n (%)3 (20.0)6 (15.0)1 (7.1)0.5831 (10.0)10 (20.8)7 (15.9)0.745
  1. Normally distributed data are presented as means ± standard deviation (SD), skewed data are presented as the median (interquartile range), and categorical data are presented as a number (percentage). Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; ECG LVH, electrocardiographic left ventricular hypertrophy; K, Potassium; Na, Sodium; TpTe, Tpeak to Tend. Values in bold indicate statistical significance (p < 0.05).

Age, QTc interval, TpTe, frontal QRS-T angle, K and creatinine were included in the multivariate logistic regression analysis. Age and QTc interval were found to be significantly different when comparing reverse-dipper BP pattern with dipper pattern or non-dipper BP pattern with dipper pattern (Table 3). QTc interval was found to be an independent risk factor for non-dipper BP pattern (Odds ratio 1.049; 95% CI 1.01-1.089; P=0.012) and reverse-dipper BP pattern (Odds ratio 1.051; 95% CI 1.007-1.098; P=0.023) in young and middle-aged hypertensive patients. Age was also found to be an independent risk factor for non-dipper BP pattern (Odds ratio 1.092; 95% CI 1.012-1.179; P=0.023) and reverse-dipper BP pattern (Odds ratio 1.116; 95% CI 1.013-1.228; P=0.026).

Table 3

Multivariate Logistic Regression Analysis for Circadian Blood Pressure Patterns

VariablesNon-dipper versus DipperReverse-dipper versus DipperReverse-dipper versus Non-dipper
OR (95% CI)POR (95% CI)POR (95% CI)P
Age1.092 (1.012-1.179)0.0231.116 (1.013-1.228)0.0261.021 (0.949-1.099)0.578
QTc1.049 (1.01-1.089)0.0121.051 (1.007-1.098)0.0231.002 (0.975-1.03)0.869
TpTe1.02 (0.966-1.077)0.4791.026 (0.967-1.089)0.3941.006 (0.972-1.041)0.73
Frontal QRS-T angle0.992 (0.961-1.024)0.6150.996 (0.963-1.03)0.8091.004 (0.987-1.021)0.649
K1.418 (0.204-9.849)0.7240.49 (0.042-5.682)0.5690.346 (0.052-2.314)0.274
Creatinine1 (0.958-1.044)0.9941.027 (0.977-1.08)0.2931.027 (0.993-1.063)0.125
  1. Abbreviations: CI, confidence interval; K, Potassium; OR, odds ratio; TpTe, Tpeak to Tend. Values in bold indicate statistical significance (p < 0.05).

To investigate whether there were associations between age or indices of ABPM and QTc in the young and middle-aged patients, Pearson’s correlation coefficients were calculated (Table 4). QTc interval duration was negatively correlated with decline rate of nocturnal SBP (r=-0.323, P=0.007) in young and middle-aged patients with essential hypertension (Figure 2). However, there was no significant correlation between other parameters and QTc.

Table 4

Correlation analysis between age or ambulatory blood pressure recordings and QTc interval in young and middle-aged patients.

QTc
rp
Age0.0390.751
24 h SBP0.0710.563
24 h DBP0.0390.749
Awake SBP0.0310.798
Awake DBP-0.0050.968
Sleep SBP0.1730.154
Sleep DBP0.1650.175
Dipping-0.3230.007
  1. Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure. Values in bold indicate statistical significance (p < 0.05).

Figure 2 The relationship between QTc and decline rate of nocturnal SBP in young and middle-aged hypertensive patients.
Figure 2

The relationship between QTc and decline rate of nocturnal SBP in young and middle-aged hypertensive patients.

4 Discussion

ABPM, which records the variation of blood pressure in 24h, has attracted more and more attention in recent years. Due to its higher reproducibility than office-measured blood pressure, ABPM has been proposed as a clinical tool to confirm office-measured hypertension diagnosis in several international guidelines [2, 3]. Based on the circadian variation of blood pressure, individuals can be divided into four types, as extreme-dipper, dipper, non-dipper and reverse-dipper [5]. Among them, dipper is considered to be a normal status. A reduced nocturnal decline rate or even increase rate in nighttime blood pressure is correlated with end organ damage and adverse cardiovascular events [6, 7, 17].

QTc is one of the most widely used ECG parameters to assess ventricular repolarization. Previous studies have revealed that abnormal prolongation of QTc interval was correlated to ventricular arrhythmia and sudden cardiac death[18, 19, 20]. For every 10ms increase in QTc interval, the risk of cardiac events increases by about 6% [21]. With the increase of 60ms in QTc interval compared to the baseline value, the TdP risk increases [22]. There have been several studies investigating the relationship between QTc interval and the nocturnal drop of blood pressure [8, 9, 10]. Passino et al demonstrated that non-dippers had longer QTc intervals than dippers in hypertensive patients. In addition, they found that circadian rhythmicity of QTc interval was affected by circadian variation of blood pressure [10]. However, Karaagac et al demonstrated that QTc interval was similar between dippers and non-dippers in patients with metabolic syndrome[8]. Moreover, there was no significant difference among dippers, non-dippers and reverse-dippers in patients with prehypertension in another study [9]. Based on the previous studies, the relationship between QTc and circadian variation of blood pressure remains controversial. To the best of our knowledge, there have been no studies assessing the relationship between QTc and reverse dipping status in young and middle-aged patients with essential hypertension.

In our study, the main finding was that QTc interval was significantly longer in non-dippers and reverse-dippers than in dippers in young and middle-aged hypertensive patients. However, QTc was similar among dippers, non-dippers and reverse-dippers in elderly patients with essential hypertension. What’s more, QTc interval duration was negatively correlated with the decline rate of nocturnal SBP in young and middle-aged hypertensive patients. Last but not least, QTc interval and age were found to be independent risk factors for non-dipper BP pattern and reverse-dipper BP pattern in young and middle-aged hypertensive patients.

The relationship between QTc interval and circadian BP variation might be explained by LVH and impaired autonomic nervous system functions. Loss of normal nocturnal BP drop is correlated to left ventricular hypertrophy. Ivanovic et al demonstrated that LVH was most prevalent among reverse-dippers compared to dippers, non-dippers, extreme-dippers [23]. Hypertrophic myocardium may lead to prolongation of QTc interval by altering ventricular repolarization and prolonging action potential duration [10]. Impairment of autonomic nervous system function plays an important role in BP variation [24]. Non-dippers exhibit increasing sympathetic activity and decreasing vagal activity. The reverse dipping status is related to even greater sympathetic activation than non-dipping status [25]. QTc interval is also related to the withdrawal of vagal drive and sympathetic overactivity. Therefore, autonomic nervous system dysfunction may contribute to QTc prolongation in young and middle-aged non-dippers and reverse-dippers. Use of diuretics may result in hypokalemia, which can lead to prolongation of QTc interval [26]. In our study, non-dippers and reverse-dippers used more diuretics than dippers in the young and middle-aged group. However, the serum level of potassium was similar among the three subgroups in young and middle-aged patients. Therefore, use of diuretics may be excluded from reasons for prolongation of QTc in non-dippers and reverse-dippers in young and middle-aged hypertensive patients.

In our study, the correlation between QTc prolongation and blunted nocturnal blood pressure drop was observed in young and middle-aged patients but not in elderly patients. Older age itself is a risk factor for QTc interval prolongation [27]. Elderly people tend to have a longer QTc interval than young and middle-aged people. In addition, elderly patients may have longer histories of hypertension than young and middle-aged patients, resulting in greater LVH which is related to the prolonging of QTc interval. The findings of our study may help to explain the conflicting results of previous studies.

Tanriverdi et al demonstrated that frontal QRS-T angle was smaller in patients with dipper hypertension than in patients with non-dipper hypertension [28]. On the contrary, there was no significant difference among dippers, non-dippers and reverse-dippers in both the young and middle-aged group and the elderly group with respect to QRS-T angle in our study. The inclusion and exclusion criteria in Tanriverdi’s study were quite similar to the criteria in our study. However, their study focused on patients in Turkey, while our study included Chinese patients with essential hypertension.

In our study, heart rate was significantly different among dippers, non-dippers and reverse-dippers in elderly patients with essential hypertension. Moreover, heart rate was lowest in revere-dippers and highest in non-dippers in elderly hypertensive patients, which was inconsistent with previous studies [9, 28]. The reverse dipping status is related to the greatest sympathetic activation, which may result in higher heart rate [25]. However, in our study, reverse-dippers had the lowest heart rate among the three subgroups in elderly hypertensive patients. Therefore, other mechanisms may be involved in the effect of BP variation on heart rate. More studies are needed to further investigate the correlation between heart rate and circadian BP variation.

Recently, the Monitorización Ambulatoria para Predicción de Eventos Cardiovasculares (MAPEC) study found that the reduction of sleep time SBP and correction of blunted night blood pressure drop through a night time antihypertensive treatment strategy can most efficiently lower the risks of stroke and cardiovascular diseases [29, 30]. In our study, only young and middle-aged patients with dipper hypertension exhibited a shorter QTc interval than non-dippers and reverse dippers. The findings of our study may suggest use of ABPM and correction of blunted nocturnal blood pressure drop at an early stage.

5 Conclusion

Our study suggests that there is a correlation between QTc interval and the circadian variation of blood pressure in young and middle-aged hypertensive patients but not in the elderly. We found that QTc interval is a risk factor for non-dipper and reverse-dipper status in young and middle-aged hypertensive patients. What’s more, QTc interval is negatively correlated with decline rate of nocturnal SBP. The finding of our study may help to explain the conflicting results of previous studies.


#Liyuan Yan and Jianling Jin contributed equally to this work and should be considered as co-first authors.


Acknowledgements

Funding: This work was supported by the National Natural Science Foundation of China (Award Number: 81700297, 81770327).

  1. Study limitations: There were several potential limitations of our study. First, the limited number of patients is the main limitation of our study. Second, due to the retrospective design, we cannot investigate the causal relationship between QTc interval and the circadian variation of blood pressure in young and middle-aged patients. Prospective studies are needed to investigate if prolonged QTc interval observed in young and middle-aged hypertensive patients with non-dipping status or reverse-dipping status with compared to dippers is related to ventricular arrhythmia.

  2. Conflict of interest

    Conflict of interest statement: Authors declare no conflict of interest.

References

[1] Messerli FH, Williams B, Ritz E. Essential hypertension. The Lancet. 2007;370(9587):591-60310.1016/S0140-6736(07)61299-9Search in Google Scholar

[2] Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e484-e59410.1161/CIR.0000000000000596Search in Google Scholar

[3] Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-10410.1201/9780429199189-75Search in Google Scholar

[4] Cho M-C. Clinical Significance and Therapeutic Implication of Nocturnal Hypertension: Relationship between Nighttime Blood Pressure and Quality of Sleep. Korean Circulation Journal. 2019;49(9)10.4070/kcj.2019.0245Search in Google Scholar

[5] Hermida RC, Ayala DE, Portaluppi F. Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv Drug Deliv Rev. 2007;59(9-10):904-92210.1016/j.addr.2006.08.003Search in Google Scholar

[6] Routledge FS, McFetridge-Durdle JA, Dean CR. Night-time blood pressure patterns and target organ damage: A review. Canadian Journal of Cardiology. 2007;23(2):132-13810.1016/S0828-282X(07)70733-XSearch in Google Scholar

[7] Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20(11):2183-218910.1097/00004872-200211000-00017Search in Google Scholar PubMed

[8] Karaagac K, Tenekecioglu E, Yontar OC, Kuzeytemiz M, Vatansever F, Tutuncu A, et al. Effect of non-dipper and dipper blood pressure patterns on Tp-Te interval and Tp-Te/QT ratio in patients with metabolic syndrome. Int J Clin Exp Med. 2014;7(5):1397-1403Search in Google Scholar

[9] Tanindi A, Alhan A, Tore HF. Tp-e/QT ratio and QT dispersion with respect to blood pressure dipping pattern in prehypertension. Blood Press Monit. 2015;20(2):69-7310.1097/MBP.0000000000000090Search in Google Scholar PubMed

[10] Passino C, Magagna A, Conforti F, Buralli S, Kozakova M, Palombo C, et al. Ventricular repolarization is prolonged in nondipper hypertensive patients: role of left ventricular hypertrophy and autonomic dysfunction. J Hypertens. 2003;21(2):445-45110.1097/00004872-200302000-00038Search in Google Scholar PubMed

[11] Ma S, Zhao H, Wang Y. Characteristic of blood pressure profile in elderly hypertensive patients with chronic kidney disease: a tertiary hospital-based study. Zhonghua yi xue za zhi. 2015;95(36):2938-2942Search in Google Scholar

[12] Abraham NS, Hartman C, Richardson P, Castillo D, Street RL, Jr., Naik AD. Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients. Circulation. 2013;128(17):1869-187710.1161/CIRCULATIONAHA.113.004747Search in Google Scholar PubMed

[13] Dekker JM. The value of the heart-rate corrected QT-interval for cardiovascular risk stratification. Eur Heart J. 1999;20(4):250-251Search in Google Scholar

[14] Aro AL, Reinier K, Rusinaru C, Uy-Evanado A, Darouian N, Phan D, et al. Electrical risk score beyond the left ventricular ejection fraction: prediction of sudden cardiac death in the Oregon Sudden Unexpected Death Study and the Atherosclerosis Risk in Communities Study. Eur Heart J. 2017;38(40):3017-302510.1093/eurheartj/ehx331Search in Google Scholar

[15] Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, et al. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol. 1985;6(3):572-58010.1016/S0735-1097(85)80115-7Search in Google Scholar

[16] Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37(2):161-18610.1016/0002-8703(49)90562-1Search in Google Scholar

[17] Myredal A, Friberg P, Johansson M. Elevated myocardial repolarization lability and arterial baroreflex dysfunction in healthy individuals with nondipping blood pressure pattern. Am J Hypertens. 2010;23(3):255-25910.1038/ajh.2009.252Search in Google Scholar PubMed

[18] Schwartz PJ, Woosley RL. Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes. J Am Coll Cardiol. 2016;67(13):1639-165010.1016/j.jacc.2015.12.063Search in Google Scholar PubMed

[19] Trinkley KE, Page RL, 2nd, Lien H, Yamanouye K, Tisdale JE. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin. 2013;29(12):1719-172610.1185/03007995.2013.840568Search in Google Scholar PubMed

[20] Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation. 1978;57(6):1074-107710.1161/01.CIR.57.6.1074Search in Google Scholar PubMed

[21] Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, et al. Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339(14):960-96510.1056/NEJM199810013391404Search in Google Scholar PubMed

[22] International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Anti-arrhythmic Drugs; availability. Notice. Federal register. 2005;70(202):61134-61135Search in Google Scholar

[23] Ivanovic BA, Tadic MV, Celic VP. To dip or not to dip? The unique relationship between different blood pressure patterns and cardiac function and structure. J Hum Hypertens. 2013;27(1):62-7010.1038/jhh.2011.83Search in Google Scholar PubMed

[24] Dauphinot V, Gosse P, Kossovsky MP, Schott AM, Rouch I, Pichot V, et al. Autonomic nervous system activity is independently associated with the risk of shift in the non-dipper blood pressure pattern. Hypertens Res. 2010;33(10):1032-103710.1038/hr.2010.130Search in Google Scholar PubMed

[25] Grassi G, Seravalle G, Quarti-Trevano F, Dell’Oro R, Bombelli M, Cuspidi C, et al. Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension. 2008;52(5):925-93110.1161/HYPERTENSIONAHA.108.116368Search in Google Scholar PubMed

[26] Tomaselli Muensterman E, Tisdale JE. Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review. Pharmacotherapy. 2018;38(8):813-82110.1002/phar.2146Search in Google Scholar PubMed

[27] Tisdale JE, Jaynes HA, Kingery JR, Mourad NA, Trujillo TN, Overholser BR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013;6(4):479-48710.1161/CIRCOUTCOMES.113.000152Search in Google Scholar PubMed PubMed Central

[28] Tanriverdi Z, Unal B, Eyuboglu M, Bingol Tanriverdi T, Nurdag A, Demirbag R. The importance of frontal QRS-T angle for predicting non-dipper status in hypertensive patients without left ventricular hypertrophy. Clin Exp Hypertens. 2018;40(4):318-32310.1080/10641963.2017.1377214Search in Google Scholar PubMed

[29] Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27(8):1629-165110.3109/07420528.2010.510230Search in Google Scholar PubMed

[30] Hermida RC. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project. Chronobiol Int. 2016;33(7):906-93610.1080/07420528.2016.1181078Search in Google Scholar PubMed

Received: 2019-11-14
Accepted: 2020-01-07
Published Online: 2020-03-06

© 2020 Liyuan Yan et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Article
  2. MicroRNA-451b participates in coronary heart disease by targeting VEGFA
  3. Case Report
  4. A combination therapy for Kawasaki disease with severe complications: a case report
  5. Vitamin E for prevention of biofilm-caused Healthcare-associated infections
  6. Research Article
  7. Differential diagnosis: retroperitoneal fibrosis and oncological diseases
  8. Optimization of the Convolutional Neural Networks for Automatic Detection of Skin Cancer
  9. NEAT1 promotes LPS-induced inflammatory injury in macrophages by regulating miR-17-5p/TLR4
  10. Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
  11. Effects of extracorporeal magnetic stimulation in fecal incontinence
  12. Case Report
  13. Mixed germ cell tumor of the endometrium: a case report and literature review
  14. Bowel perforation after ventriculoperitoneal-shunt placement: case report and review of the literature
  15. Research Article
  16. Prognostic value of lncRNA HOTAIR in colorectal cancer : a meta-analysis
  17. Case Report
  18. Treatment of insulinomas by laparoscopic radiofrequency ablation: case reports and literature review
  19. Research Article
  20. The characteristics and nomogram for primary lung papillary adenocarcinoma
  21. Undiagnosed pheochromocytoma presenting as a pancreatic tumor: A case report
  22. Bioinformatics Analysis of the Expression of ATP binding cassette subfamily C member 3 (ABCC3) in Human Glioma
  23. Diagnostic value of recombinant heparin-binding hemagglutinin adhesin protein in spinal tuberculosis
  24. Primary cutaneous DLBCL non-GCB type: challenges of a rare case
  25. LINC00152 knock-down suppresses esophageal cancer by EGFR signaling pathway
  26. Case Report
  27. Life-threatening anaemia in patient with hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
  28. Research Article
  29. QTc interval predicts disturbed circadian blood pressure variation
  30. Shoulder ultrasound in the diagnosis of the suprascapular neuropathy in athletes
  31. The number of negative lymph nodes is positively associated with survival in esophageal squamous cell carcinoma patients in China
  32. Differentiation of pontine infarction by size
  33. RAF1 expression is correlated with HAF, a parameter of liver computed tomographic perfusion, and may predict the early therapeutic response to sorafenib in advanced hepatocellular carcinoma patients
  34. LncRNA ZEB1-AS1 regulates colorectal cancer cells by miR-205/YAP1 axis
  35. Tissue coagulation in laser hemorrhoidoplasty – an experimental study
  36. Classification of pathological types of lung cancer from CT images by deep residual neural networks with transfer learning strategy
  37. Enhanced Recovery after Surgery for Lung Cancer Patients
  38. Case Report
  39. Streptococcus pneumoniae-associated thrombotic microangiopathy in an immunosuppressed adult
  40. Research Article
  41. The characterization of Enterococcus genus: resistance mechanisms and inflammatory bowel disease
  42. Case Report
  43. Inflammatory fibroid polyp: an unusual cause of abdominal pain in the upper gastrointestinal tract A case report
  44. Research Article
  45. microRNA-204-5p participates in atherosclerosis via targeting MMP-9
  46. LncRNA LINC00152 promotes laryngeal cancer progression by sponging miR-613
  47. Can keratin scaffolds be used for creating three-dimensional cell cultures?
  48. miRNA-186 improves sepsis induced renal injury via PTEN/PI3K/AKT/P53 pathway
  49. Case Report
  50. Delayed bowel perforation after routine distal loopogram prior to ileostomy closure
  51. Research Article
  52. Diagnostic accuracy of MALDI-TOF mass spectrometry for the direct identification of clinical pathogens from urine
  53. The R219K polymorphism of the ATP binding cassette subfamily A member 1 gene and susceptibility to ischemic stroke in Chinese population
  54. miR-92 regulates the proliferation, migration, invasion and apoptosis of glioma cells by targeting neogenin
  55. Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma
  56. NF2 inhibits proliferation and cancer stemness in breast cancer
  57. Body composition indices and cardiovascular risk in type 2 diabetes. CV biomarkers are not related to body composition
  58. S100A6 promotes proliferation and migration of HepG2 cells via increased ubiquitin-dependent degradation of p53
  59. Review Article
  60. Focus on localized laryngeal amyloidosis: management of five cases
  61. Research Article
  62. NEAT1 aggravates sepsis-induced acute kidney injury by sponging miR-22-3p
  63. Pericentric inversion in chromosome 1 and male infertility
  64. Increased atherogenic index in the general hearing loss population
  65. Prognostic role of SIRT6 in gastrointestinal cancers: a meta-analysis
  66. The complexity of molecular processes in osteoarthritis of the knee joint
  67. Interleukin-6 gene −572 G > C polymorphism and myocardial infarction risk
  68. Case Report
  69. Severe anaphylactic reaction to cisatracurium during anesthesia with cross-reactivity to atracurium
  70. Research Article
  71. Rehabilitation training improves nerve injuries by affecting Notch1 and SYN
  72. Case Report
  73. Myocardial amyloidosis following multiple myeloma in a 38-year-old female patient: A case report
  74. Research Article
  75. Identification of the hub genes RUNX2 and FN1 in gastric cancer
  76. miR-101-3p sensitizes non-small cell lung cancer cells to irradiation
  77. Distinct functions and prognostic values of RORs in gastric cancer
  78. Clinical impact of post-mortem genetic testing in cardiac death and cardiomyopathy
  79. Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis
  80. Review Article
  81. The role of osteoprotegerin in the development, progression and management of abdominal aortic aneurysms
  82. Research Article
  83. Identification of key microRNAs of plasma extracellular vesicles and their diagnostic and prognostic significance in melanoma
  84. miR-30a-3p participates in the development of asthma by targeting CCR3
  85. microRNA-491-5p protects against atherosclerosis by targeting matrix metallopeptidase-9
  86. Bladder-embedded ectopic intrauterine device with calculus
  87. Case Report
  88. Mycobacterial identification on homogenised biopsy facilitates the early diagnosis and treatment of laryngeal tuberculosis
  89. Research Article
  90. The will of young minors in the terminal stage of sickness: A case report
  91. Extended perfusion protocol for MS lesion quantification
  92. Identification of four genes associated with cutaneous metastatic melanoma
  93. Case Report
  94. Thalidomide-induced serious RR interval prolongation (longest interval >5.0 s) in multiple myeloma patient with rectal cancer: A case report
  95. Research Article
  96. Voluntary exercise and cardiac remodeling in a myocardial infarction model
  97. Electromyography as an intraoperative test to assess the quality of nerve anastomosis – experimental study on rats
  98. Case Report
  99. CT findings of severe novel coronavirus disease (COVID-19): A case report of Heilongjiang Province, China
  100. Commentary
  101. Directed differentiation into insulin-producing cells using microRNA manipulation
  102. Research Article
  103. Culture-negative infective endocarditis (CNIE): impact on postoperative mortality
  104. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome
  105. Plasma microRNAs in human left ventricular reverse remodelling
  106. Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis
  107. Risk factors for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage
  108. Problems and solutions of personal protective equipment doffing in COVID-19
  109. Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients
  110. Review Article
  111. Gastroenterological complications in kidney transplant patients
  112. Research Article
  113. CXCL13 concentration in latent syphilis patients with treatment failure
  114. A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction
  115. Case Report
  116. Clinicopathological analysis of composite lymphoma: A two-case report and literature review
  117. Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
  118. Research Article
  119. Inhibition of vitamin D analog eldecalcitol on hepatoma in vitro and in vivo
  120. CCTs as new biomarkers for the prognosis of head and neck squamous cancer
  121. Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet
  122. 72 hour Holter monitoring, 7 day Holter monitoring, and 30 day intermittent patient-activated heart rhythm recording in detecting arrhythmias in cryptogenic stroke patients free from arrhythmia in a screening 24 h Holter
  123. FOXK2 downregulation suppresses EMT in hepatocellular carcinoma
  124. Case Report
  125. Total parenteral nutrition-induced Wernicke’s encephalopathy after oncologic gastrointestinal surgery
  126. Research Article
  127. Clinical prediction for outcomes of patients with acute-on-chronic liver failure associated with HBV infection: A new model establishment
  128. Case Report
  129. Combination of chest CT and clinical features for diagnosis of 2019 novel coronavirus pneumonia
  130. Research Article
  131. Clinical significance and potential mechanisms of miR-223-3p and miR-204-5p in squamous cell carcinoma of head and neck: a study based on TCGA and GEO
  132. Review Article
  133. Hemoperitoneum caused by spontaneous rupture of hepatocellular carcinoma in noncirrhotic liver. A case report and systematic review
  134. Research Article
  135. Voltage-dependent anion channels mediated apoptosis in refractory epilepsy
  136. Prognostic factors in stage I gastric cancer: A retrospective analysis
  137. Circulating irisin is linked to bone mineral density in geriatric Chinese men
  138. Case Report
  139. A family study of congenital dysfibrinogenemia caused by a novel mutation in the FGA gene: A case report
  140. Research Article
  141. CBCT for estimation of the cemento-enamel junction and crestal bone of anterior teeth
  142. Case Report
  143. Successful de-escalation antibiotic therapy using cephamycins for sepsis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia: A sequential 25-case series
  144. Research Article
  145. Influence factors of extra-articular manifestations in rheumatoid arthritis
  146. Assessment of knowledge of use of electronic cigarette and its harmful effects among young adults
  147. Predictive factors of progression to severe COVID-19
  148. Procedural sedation and analgesia for percutaneous trans-hepatic biliary drainage: Randomized clinical trial for comparison of two different concepts
  149. Acute chemoradiotherapy toxicity in cervical cancer patients
  150. IGF-1 regulates the growth of fibroblasts and extracellular matrix deposition in pelvic organ prolapse
  151. NANOG regulates the proliferation of PCSCs via the TGF-β1/SMAD pathway
  152. An immune-relevant signature of nine genes as a prognostic biomarker in patients with gastric carcinoma
  153. Computer-aided diagnosis of skin cancer based on soft computing techniques
  154. MiR-1225-5p acts as tumor suppressor in glioblastoma via targeting FNDC3B
  155. miR-300/FA2H affects gastric cancer cell proliferation and apoptosis
  156. Hybrid treatment of fibroadipose vascular anomaly: A case report
  157. Surgical treatment for common hepatic aneurysm. Original one-step technique
  158. Neuropsychiatric symptoms, quality of life and caregivers’ burden in dementia
  159. Predictor of postoperative dyspnea for Pierre Robin Sequence infants
  160. Long non-coding RNA FOXD2-AS1 promotes cell proliferation, metastasis and EMT in glioma by sponging miR-506-5p
  161. Analysis of expression and prognosis of KLK7 in ovarian cancer
  162. Circular RNA circ_SETD2 represses breast cancer progression via modulating the miR-155-5p/SCUBE2 axis
  163. Glial cell induced neural differentiation of bone marrow stromal cells
  164. Case Report
  165. Moraxella lacunata infection accompanied by acute glomerulonephritis
  166. Research Article
  167. Diagnosis of complication in lung transplantation by TBLB + ROSE + mNGS
  168. Case Report
  169. Endometrial cancer in a renal transplant recipient: A case report
  170. Research Article
  171. Downregulation of lncRNA FGF12-AS2 suppresses the tumorigenesis of NSCLC via sponging miR-188-3p
  172. Case Report
  173. Splenic abscess caused by Streptococcus anginosus bacteremia secondary to urinary tract infection: a case report and literature review
  174. Research Article
  175. Advances in the role of miRNAs in the occurrence and development of osteosarcoma
  176. Rheumatoid arthritis increases the risk of pleural empyema
  177. Effect of miRNA-200b on the proliferation and apoptosis of cervical cancer cells by targeting RhoA
  178. LncRNA NEAT1 promotes gastric cancer progression via miR-1294/AKT1 axis
  179. Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis
  180. Comparison of low-molecular-weight heparins in thromboprophylaxis of major orthopaedic surgery – randomized, prospective pilot study
  181. Case Report
  182. A case of SLE with COVID-19 and multiple infections
  183. Research Article
  184. Circular RNA hsa_circ_0007121 regulates proliferation, migration, invasion, and epithelial–mesenchymal transition of trophoblast cells by miR-182-5p/PGF axis in preeclampsia
  185. SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis
  186. Case Report
  187. A case report of cervical pregnancy after in vitro fertilization complicated by tuberculosis and a literature review
  188. Review Article
  189. Serrated lesions of the colon and rectum: Emergent epidemiological data and molecular pathways
  190. Research Article
  191. Biological properties and therapeutic effects of plant-derived nanovesicles
  192. Case Report
  193. Clinical characterization of chromosome 5q21.1–21.3 microduplication: A case report
  194. Research Article
  195. Serum calcium levels correlates with coronary artery disease outcomes
  196. Rapunzel syndrome with cholangitis and pancreatitis – A rare case report
  197. Review Article
  198. A review of current progress in triple-negative breast cancer therapy
  199. Case Report
  200. Peritoneal-cutaneous fistula successfully treated at home: A case report and literature review
  201. Research Article
  202. Trim24 prompts tumor progression via inducing EMT in renal cell carcinoma
  203. Degradation of connexin 50 protein causes waterclefts in human lens
  204. GABRD promotes progression and predicts poor prognosis in colorectal cancer
  205. The lncRNA UBE2R2-AS1 suppresses cervical cancer cell growth in vitro
  206. LncRNA FOXD3-AS1/miR-135a-5p function in nasopharyngeal carcinoma cells
  207. MicroRNA-182-5p relieves murine allergic rhinitis via TLR4/NF-κB pathway
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2020-0021/html
Scroll to top button